Literature DB >> 25205089

The RND protein is involved in the vulnibactin export system in Vibrio vulnificus M2799.

Hiroaki Kawano1, Katsushiro Miyamoto1, Megumi Yasunobe1, Masahiro Murata1, Tomoka Myojin1, Takahiro Tsuchiya1, Tomotaka Tanabe2, Tatsuya Funahashi2, Takaji Sato3, Takashi Azuma3, Yoshiki Mino3, Hiroshi Tsujibo4.   

Abstract

Vibrio vulnificus, an opportunistic marine bacterium that causes a serious, often fatal, infection in humans, requires iron for its pathogenesis. This bacterium exports vulnibactin for iron acquisition from the environment. The mechanisms of vulnibactin biosynthesis and ferric-vulnibactin uptake systems have recently been reported, while the vulnibactin export system has not been reported. Mutant growth under low-iron concentration conditions and a bioassay of the culture supernatant indicate that the VV1_0612 protein plays a crucial role in the vulnibactin secretion as a component of the resistance-nodulation-division (RND)-type efflux system in V. vulnificus M2799. To identify which RND protein(s) together with VV1_0612 TolC constituted the RND efflux system for vulnibactin secretion, deletion mutants of 11 RND protein-encoding genes were constructed. The growth inhibition of a multiple mutant (Δ11) of the RND protein-encoding genes was observed 6 h after the beginning of the culture. Furthermore, ΔVV1_1681 exhibited a growth curve that was similar to that of Δ11, while the multiple mutant except ΔVV1_1681 showed the same growth as the wild-type strain. These results indicate that the VV1_1681 protein is involved in the vulnibactin export system of V. vulnificus M2799. This is the first genetic evidence that vulnibactin is secreted through the RND-type efflux systems in V. vulnificus.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  RND-type efflux system; Vibrio vulnificus; Vulnibactin secretion

Mesh:

Substances:

Year:  2014        PMID: 25205089     DOI: 10.1016/j.micpath.2014.09.001

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  7 in total

1.  Functional analysis of Vibrio vulnificus RND efflux pumps homologous to Vibrio cholerae VexAB and VexCD, and to Escherichia coli AcrAB.

Authors:  Seunghwa Lee; Ji-Hyun Yeom; Sojin Seo; Minho Lee; Sarang Kim; Jeehyeon Bae; Kangseok Lee; Jihwan Hwang
Journal:  J Microbiol       Date:  2015-03-04       Impact factor: 3.422

2.  Expression, purification, crystallization and X-ray crystallographic analysis of the periplasmic binding protein VatD from Vibrio vulnificus M2799.

Authors:  Nao Miyano; Tomoko Igarashi; Hiroaki Kawano; Katsushiro Miyamoto; Takahiro Tsuchiya; Koji Tomoo; Hiroshi Tsujibo
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-07-29       Impact factor: 1.056

3.  ToxR Mediates the Antivirulence Activity of Phenyl-Arginine-β-Naphthylamide To Attenuate Vibrio cholerae Virulence.

Authors:  Yuding Weng; Thomas F Bina; X Renee Bina; James E Bina
Journal:  Infect Immun       Date:  2021-06-16       Impact factor: 3.441

4.  TolCV1 Has Multifaceted Roles During Vibrio vulnificus Infection.

Authors:  Yue Gong; Rui Hong Guo; Joon Haeng Rhee; Young Ran Kim
Journal:  Front Cell Infect Microbiol       Date:  2021-04-30       Impact factor: 5.293

5.  Identification of Key Functions Required for Production and Utilization of the Siderophore Piscibactin Encoded by the High-Pathogenicity Island irp-HPI in Vibrionaceae.

Authors:  Marta A Lages; Lucía Ageitos; Jaime Rodríguez; Carlos Jiménez; Manuel L Lemos; Miguel Balado
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

6.  The Vibrio cholerae VexGH RND Efflux System Maintains Cellular Homeostasis by Effluxing Vibriobactin.

Authors:  Dillon E Kunkle; X Renee Bina; James E Bina
Journal:  MBio       Date:  2017-05-16       Impact factor: 7.867

Review 7.  Iron-Utilization System in Vibrio vulnificus M2799.

Authors:  Katsushiro Miyamoto; Hiroaki Kawano; Naoko Okai; Takeshi Hiromoto; Nao Miyano; Koji Tomoo; Takahiro Tsuchiya; Jun Komano; Tomotaka Tanabe; Tatsuya Funahashi; Hiroshi Tsujibo
Journal:  Mar Drugs       Date:  2021-12-17       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.